TY - JOUR
T1 - Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention
T2 - a nationwide cohort study
AU - Lamberts, Morten
AU - Olesen, Jonas Bjerring
AU - Ruwald, Martin Huth
AU - Hansen, Carolina Malta
AU - Karasoy, Deniz
AU - Kristensen, Søren Lund
AU - Køber, Lars
AU - Torp-Pedersen, Christian
AU - Gislason, Gunnar Hilmar
AU - Hansen, Morten Lock
PY - 2012
Y1 - 2012
N2 - Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or undergoing percutaneous coronary intervention. We investigated the risk and time frame for bleeding following myocardial infarction/percutaneous coronary intervention in patients with atrial fibrillation according to antithrombotic treatment.
AB - Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or undergoing percutaneous coronary intervention. We investigated the risk and time frame for bleeding following myocardial infarction/percutaneous coronary intervention in patients with atrial fibrillation according to antithrombotic treatment.
U2 - 10.1161/CIRCULATIONAHA.112.114967
DO - 10.1161/CIRCULATIONAHA.112.114967
M3 - Journal article
C2 - 22869839
VL - 126
SP - 1185
EP - 1193
JO - Circulation (Baltimore)
JF - Circulation (Baltimore)
SN - 0009-7322
IS - 10
ER -